Cargando…
The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C
The World Health Organization (WHO) has declared that hepatitis C virus (HCV) should be eliminated as a public health threat. A key recommendation to reach this elimination goal, is to reduce new infections by 90% and liver-related mortality by 65%. Highly effective direct-acting antiviral agents (D...
Autores principales: | Popping, Stephanie, Cento, Valeria, García, Federico, Ceccherini-Silberstein, Francesca, Seguin-Devaux, Carole, Vijver, David AMC, Boucher, Charles A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mediscript Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038130/ https://www.ncbi.nlm.nih.gov/pubmed/30050681 |
Ejemplares similares
-
The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral Failures
por: Popping, Stephanie, et al.
Publicado: (2021) -
Hepatitis C virus elimination: time for disruptive innovation
por: Klein, Marina B
Publicado: (2019) -
Leaving no one behind: Towards equitable global elimination of hepatitis C
por: Dahl, Elin Hoffmann, et al.
Publicado: (2020) -
The path to hepatitis C elimination: who are we leaving behind and why?
por: Rockstroh, Jurgen K., et al.
Publicado: (2023) -
The role of the Primary Healthcare Network in Iran in hepatitis C virus elimination by 2030
por: Behzadifar, Masoud, et al.
Publicado: (2018)